Evidence map›Paper›PMID 25749908›Full record

Trial reportEuropean journal of pediatrics2015

Demonstration of the effectiveness of zinc in diarrhoea of children living in Switzerland.

Pierre Alex Crisinel, Marie-Elise Verga, Konan Sallert Alexis Kouame, Anne Pittet, Céline Gasser Rey-Bellet, Olivier Fontaine, Ermindo Roberto Di Paolo, Mario Gehri

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Oral zinc for treating diarrhoea in children.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Acute Infectious Diarrhea and Gastroenteritis in Children.Current infectious disease reports · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. The ZnBiochimica et biophysica acta. Molecular basis of disease · 2017
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pierre Alex CrisinelMedico-Surgical Paediatric Department, Lausanne University Hospital, Lausanne, Switzerland, pierre-alex.crisinel@chuv.ch.
Marie-Elise Verga
Konan Sallert Alexis Kouame
Anne Pittet
Céline Gasser Rey-Bellet
Olivier Fontaine
Ermindo Roberto Di Paolo
Mario Gehri
University of Lausanne · CHWorld Health Organization · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledWe designed a double-blinded randomized clinical trial of zinc (10 or 20 mg of zinc sulphate for 2-5 month-old or 6-59 month-old children, respectively, during 10 days) vs. placebo in otherwise healthy children aged 2 months to 5 years who presented with acute diarrhoea (i.e. ≥3 stools/day for less than 72 h). Eighty-seven patients (median age 14 months; range 3.1-58.3) were analysed in an intention-to-treat approach. Forty-two patients took zinc and 45 placebo. There was no difference in the duration nor in the frequency of diarrhoea, but only 5% of the zinc group still had diarrhoea at 120 h of treatment compared to 20% in the placebo group (P = 0.05). Thirty-one patients (13 zinc and 18 placebo) were available for per-protocol analyses. The median (IQR) duration of diarrhoea in zinc-treated patients was 47.5 h (18.3-72) and differed significantly from the placebo group (median 76.3; IQR 52.8-137) (P = 0.03). The frequency of diarrhoea was also lower in the zinc group (P = 0.02).

conclusionzinc treatment decreases the frequency and severity of diarrhoea in children aged 2 months to 5 years living in Switzerland. However, the intention-to-treat analysis reveals compliance issues that question the proper duration of treatment and the choice of optimal pharmaceutical formulation.

Indexed as

Acute DiseaseChild, PreschoolDiarrheaDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansInfantMaleSeverity of Illness IndexSwitzerlandTime FactorsTreatment OutcomeZinc CompoundsZinc SulfateZinc CompoundsZinc Sulfate

Identifiers

PMID25749908
OpenAlexW2016675875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.